Clin2
NCT07702461Likely a fitRecruiting

Resistance training survey for people on weight loss meds

Obesity & OverweightDiabetes (DM)

Part of Brain & nervous system, Hormones & metabolism clinical trials.

This trial is an online survey to understand how people taking GLP-1 medications (like Ozempic or Wegovy) are doing with resistance training. If you're an adult on a stable dose of a GLP-1 med for weight or diabetes, your input can help shape better exercise advice.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 years old or older
  • You are currently taking a GLP-1 medication (like Ozempic, Wegovy, Mounjaro, etc.)
  • You have been on that medication for at least 3 months
  • Your dose has been the same for the past 4 to 8 weeks
  • You are using the medication for type 2 diabetes, weight loss, or weight management
  • You can read and answer a survey in English and are not currently or planning to be pregnant

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07787533Not yet recruiting
Strength training program for women taking GLP-1 medication

This study tests a 12-week digital strength training program for women aged 40–54 who have recently started taking a GLP-1 medication for weight management. The program uses a smartphone app to guide bodyweight exercises at home, with the goal of preserving muscle while losing weight.

Baton Rouge, Louisiana
NCT07554417Not yet recruiting· Phase 4
Exercise and diet to prevent muscle loss on GLP-1 meds

This study tests whether a 12-week program of exercise and personalized nutrition can help adults who are obese and taking GLP-1 weight-loss medications maintain muscle and bone while losing fat. It aims to improve strength, fitness, and overall function during treatment.

Houston, Texas
NCT07457437Recruiting
Exercise and medication for weight loss in women

This study tests whether adding resistance exercise to a new weight-loss medication helps women preserve muscle while losing weight. It may be an option for women who want to protect their muscle mass during treatment.

Exeter, Devon
NCT07832084Not yet recruiting· Phase 4
Comparing weight loss medication plans after GLP-1 therapy

This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.

Pittsburgh, Pennsylvania
NCT07652333Recruiting
Strength training for muscle and mind on obesity medication

This study tests whether strength training can help adults taking new obesity medications (like Wegovy or Ozempic) maintain muscle and improve mental health. You would start the medication after your first study visit.

Pittsburgh, Pennsylvania
NCT07518407Recruiting
Nutrition Education and Diet Guidance While Using GLP-1 Medication

This study teaches adults on GLP-1 medication (like Ozempic or Wegovy) how to eat better and lose weight using a smartphone app. Researchers want to see if personalized nutrition advice helps you get better results from your medication.

Columbia, South Carolina

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.